DK0626851T3 - Anvendelse af 3,5-diamino-6-(2,3-dichlorphenyl)-1,2,4-triazin til fremstilling af et lægemiddel til behandling af visse typer af smerte og af ødem - Google Patents

Anvendelse af 3,5-diamino-6-(2,3-dichlorphenyl)-1,2,4-triazin til fremstilling af et lægemiddel til behandling af visse typer af smerte og af ødem

Info

Publication number
DK0626851T3
DK0626851T3 DK93904225T DK93904225T DK0626851T3 DK 0626851 T3 DK0626851 T3 DK 0626851T3 DK 93904225 T DK93904225 T DK 93904225T DK 93904225 T DK93904225 T DK 93904225T DK 0626851 T3 DK0626851 T3 DK 0626851T3
Authority
DK
Denmark
Prior art keywords
dichlorophenyl
diamino
triazine
edema
pain
Prior art date
Application number
DK93904225T
Other languages
Danish (da)
English (en)
Inventor
Meire Nakamura-Craig
Michael John Leach
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of DK0626851T3 publication Critical patent/DK0626851T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK93904225T 1992-02-19 1993-02-18 Anvendelse af 3,5-diamino-6-(2,3-dichlorphenyl)-1,2,4-triazin til fremstilling af et lægemiddel til behandling af visse typer af smerte og af ødem DK0626851T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929203483A GB9203483D0 (en) 1992-02-19 1992-02-19 Anti-inflammatory compounds
PCT/GB1993/000341 WO1993016700A1 (en) 1992-02-19 1993-02-18 Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and ×dema

Publications (1)

Publication Number Publication Date
DK0626851T3 true DK0626851T3 (da) 2001-12-03

Family

ID=10710643

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93904225T DK0626851T3 (da) 1992-02-19 1993-02-18 Anvendelse af 3,5-diamino-6-(2,3-dichlorphenyl)-1,2,4-triazin til fremstilling af et lægemiddel til behandling af visse typer af smerte og af ødem

Country Status (18)

Country Link
US (1) US5712277A (https=)
EP (1) EP0626851B1 (https=)
KR (1) KR950700067A (https=)
AT (1) ATE204476T1 (https=)
AU (1) AU684711B2 (https=)
CA (1) CA2129043C (https=)
CY (1) CY2299B1 (https=)
DE (1) DE69330638T2 (https=)
DK (1) DK0626851T3 (https=)
ES (1) ES2162813T3 (https=)
GB (2) GB9203483D0 (https=)
GR (1) GR3036958T3 (https=)
IL (1) IL104775A (https=)
MX (1) MX9300927A (https=)
NZ (1) NZ249197A (https=)
PT (1) PT626851E (https=)
TW (1) TW226331B (https=)
WO (1) WO1993016700A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9424766D0 (en) * 1994-12-07 1995-02-08 Wellcome Found Pharmaceutical composition
EP0800520B1 (en) * 1994-12-30 2002-06-19 The Wellcome Foundation Limited Process for the preparation of lamotrigine
GB9625795D0 (en) * 1996-12-12 1997-01-29 Smithkline Beecham Plc Novel treatment
GB9726987D0 (en) 1997-12-22 1998-02-18 Glaxo Group Ltd Compounds
DE60022333T2 (de) * 1999-04-09 2006-07-06 Euro-Celtique S.A. Natrium kanalblocker zusammensetzungen und deren verwendung
IL160523A0 (en) 2001-09-03 2004-07-25 Newron Pharm Spa PHARMACEUTICAL COMPOSITION COMPRISING GABAPENTIN OR AN ANALOGUE THEREOF AND AN alpha-AMINOAMIDE AND ITS ANALGESIC USE
ATE471147T1 (de) * 2004-09-10 2010-07-15 Newron Pharm Spa Verwendung von (r)-(halogenbenzyloxy)-benzylamino-propanamiden als natrium- und/oder calciumkanal- selektive modulatoren
CA3021424C (en) * 2015-06-12 2023-03-21 University Of Greenwich Triazine derivatives as interferon-gamma inhibitors
US12605388B2 (en) 2024-09-25 2026-04-21 Azurity Pharmaceuticals Ireland Limited Lamotrigine salts, co-crystals, and compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637688A (en) * 1970-01-09 1972-01-25 American Home Prod 6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines
US4310551A (en) * 1979-03-19 1982-01-12 Diamond Shamrock Corporation Pharmacologically active substituted 1,2,4-triazines
DD151309A5 (de) * 1979-06-01 1981-10-14 Wellcome Found Verfahren zur herstellung von substituierten aminotriazinen
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt
GB9012312D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds

Also Published As

Publication number Publication date
US5712277A (en) 1998-01-27
GB2277265A (en) 1994-10-26
GB2277265B (en) 1996-01-10
ATE204476T1 (de) 2001-09-15
IL104775A (en) 1997-02-18
CY2299B1 (en) 2003-07-04
GB9414348D0 (en) 1994-09-07
AU3509293A (en) 1993-09-13
GB9203483D0 (en) 1992-04-08
DE69330638D1 (de) 2001-09-27
GR3036958T3 (en) 2002-01-31
EP0626851B1 (en) 2001-08-22
ES2162813T3 (es) 2002-01-16
KR950700067A (ko) 1995-01-16
MX9300927A (es) 1994-08-31
JPH07503968A (ja) 1995-04-27
AU684711B2 (en) 1998-01-08
NZ249197A (en) 1997-05-26
PT626851E (pt) 2002-02-28
IL104775A0 (en) 1993-06-10
JP3713271B2 (ja) 2005-11-09
TW226331B (https=) 1994-07-11
WO1993016700A1 (en) 1993-09-02
CA2129043A1 (en) 1993-09-02
DE69330638T2 (de) 2002-06-27
EP0626851A1 (en) 1994-12-07
CA2129043C (en) 2004-01-27

Similar Documents

Publication Publication Date Title
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
PL310474A1 (en) Application of rilusole in treating neuro-aids diseases
ATE197670T1 (de) Parenterales busulfan zur behandlung von malignen krankheiten
EP0746313A4 (en) METHOD FOR TREATING SMALL Mouth Ulcers
GB0130677D0 (en) Medicaments and novel compounds
DK0668077T3 (da) Produkter, som indeholder G-CSF og TNF-bindende protein
DK0626851T3 (da) Anvendelse af 3,5-diamino-6-(2,3-dichlorphenyl)-1,2,4-triazin til fremstilling af et lægemiddel til behandling af visse typer af smerte og af ødem
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
NO970573D0 (no) Ylidenforbindelser og deres fremstilling
MY112888A (en) Use of bradykinin antagonists for the preparation of medicaments for the treatment of virus diseases.
WO1998025594A3 (en) Lamotrigine in the treatment and prophylaxis of migraine
DK0728002T3 (da) Anvendelse af 2-aminopurinderivater til behandling og forebyggelse af humant herpesvirus 7-infektioner
GB2282326A (en) Use of 3,5-diamino-6-(2,3 dichlorophenyl)-1,2,4-triazine isethionate for the treatment and prevention of dependence,tolerance and sensitization of drugs
ATE120086T1 (de) Therapeutische verwendung des 1,3-dimethylol-5,5- dimethylhydantoins.
UA31078A (uk) Інгібітор вірусу імунодефіциту людини ( даримід )
MX9706759A (es) Uso de penciclovir para el tratamiento de virus deherpes 8 humano.
DE69201975D1 (de) Pyrimido-benzothiazinderivate zur Behandlung von Entzündung, Allergie and kardiovaskulären Erkrankung.